Skip to nav Skip to content
  • Cancer Type: Gastrointestinal Tumor
  • Study Type: Supportive Care
  • NCT#:
  • Phase: N/A
Learn More
  • Overview

    Study Title:

    Development and Implementation of a Standardized 3D-Printing Application to Optimize Routine Individualized Patient-Specific Surgical Care of Hepatobiliary Tumors

    Objective:

    The goal for Phase 1 will be to develop a structured and collaborative process between Moffitt Cancer Center and the 3D Printing Lab, located at the USF Health Morsani College of Medicine. The director of the 3D Printing Lab is Dr. Decker (co-investigator). The methodology of 3D printing differs with desired outcome, and certain methods are better suited for recreating certain anatomies. Proper selection of technique and materials is required to create an accurate model specific for clinical use. Thus, it is important to develop and implement a standardized 3D printing workflow within existing multidisciplinary cancer care with an accessible procedural manual. The P3D-LM printing workflow and procedural manual will be established/created during Phase 1. P3D-LM will not be printed during Phase 1, nor will data be collected from participants or electronic medical records (EMR).

  • Inclusion Criteria

      P3D-LM Cohort Inclusion Criteria
    • Age > 18 years.
    • Diagnosis of hepatobiliary tumor (primary or secondary), confirmed by biopsy and/or imaging.
    • Case presentation at the Hepatobiliary Multidisciplinary Tumor Board (HB-MTB) at Moffitt Cancer Center.
    • Scheduled surgical procedure for the management of hepatobiliary tumor. P3D-BM Cohort Inclusion Criteria
    • Age > 18 years.
    • Diagnosis of breast cancer (including those who are considered for lumpectomy or a mastectomy), confirmed by biopsy and/or imaging.
    • Case presentation at a Multidisciplinary Tumor Board at Moffitt Cancer Center.
    • Scheduled surgical procedure for the management of breast cancer.
  • Exclusion Criteria

      Key Exclusion Criteria
    • Not meeting all of the inclusion criteria.

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.

Clinical Trial Search